2025-05-22 06:01:36 pm | Source: reuters
India`s Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs
Sun Pharmaceutical, India's largest drugmaker by revenue, reported a rise in adjusted quarterly profit on Thursday, driven by strong domestic demand for its drugs to treat rare diseases.
The Mumbai-based firm's consolidated profit before exceptional items and tax rose 24% to 36.16 billion rupees ($420.7 million) in the three months ended March 31.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or
investment advice. Investments in financial markets are subject to market risks, and past performance is
not indicative of future results. Readers are strongly advised to consult a licensed financial expert or
advisor for tailored advice before making any investment decisions. The data and information presented
in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the
content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
Japan, India in talks to jointly develop Rajasthan r...
The Economy Observer :Jan?26 IIP: Grew at a three-mo...
Gold, silver surge over 1 pc amid escalating conflic...
Rupee hits all-time low against US dollar on Wednesday
Union Home Minister Amit Shah unveils mascot of Cens...
Inside India`s `Smartest` GIFT City`s 24x7 Command C...
The Economy Observer :Fiscal monthly: Center and sta...
Mahindra Holidays rises on signing new resort in Dapoli
Gujarat`s SSIP 2.0 transforms Ahmedabad polytechnic ...
Paras Defence zooms on signing MoU with Green Optics
